Salivary Glands Cancers

سجل دخولك لتتبع تقدمك اشترك الآن
10 أقسام

سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Background

  • Salivary gland cancers make up 6% of all head and neck tumors
  • Most commonly arise in the parotid gland (80%)
  • Among salivary gland neoplasms, 10-15% arise in the submandibular glands
  • These tumors present usually in the 6th decade of life
  • Salivary gland cancers are mostly benign
  • Submandibular, sublingual and minor salivary gland tumors are more likely to be malignant

Version 2

 

Definition

 

Neoplasms arising from the major (parotid, submandibular, sublingual) or minor salivary glands, ranging from benign to malignant.

 

Epidemiology

  • Incidence: 3-6% of all head and neck tumors
  • Age: Peak incidence in 6th-7th decade
  • Gender: Slight female predominance for benign tumors; equal distribution for malignant
  • ★ Most common site: Parotid gland (80% of all salivary tumors)
  • ★ Rule of 80s:
    • 80% of salivary tumors occur in parotid
    • 80% of parotid tumors are benign
    • 80% of benign parotid tumors are pleomorphic adenomas

Risk Factors

  • Radiation exposure (latency period: 15-20 years)
  • Prior head/neck radiation therapy
  • Occupational exposure (rubber manufacturing, hairdressing)
  • Viral infections (EBV, HIV)
  • Genetic syndromes (Li-Fraumeni)

 

سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Types

Salivary gland tumor Notes
Pleomorphic adenoma (benign mixed tumor)
  • Most common tumor (affects the superficial lobe of the parotid gland)
  • Composed of chondromyxoid stroma and epithelium
  • Female predominance (30 - 50 years of age)
  • Risk factors: radiation
  • Mostly benign (can undergo malignant transformation)
  • High recurrence rate (especially if incompletely excised or ruptured intraoperatively
Warthin’s tumor (papillary cystadenoma lymphoatosum)
  • Benign cystic tumor with germinal centers
  • Can be bilateral or multifocal
  • Common in smokers
  • Male predominance
Mucoepidermoid carcinoma
  • Most common malignant tumor
  • Mostly occurs in the parotid gland
  • Mucinous and squamous components

 

Version 2

Tumor Type Frequency Demographics Key Features Malignant Potential
★ Pleomorphic adenoma
(Benign mixed tumor)
50-60% of parotid tumors
★ MOST COMMON overall
F > M
30-50 years
• Painless, slow-growing
• Mobile mass
• Chondromyxoid stroma + epithelium
• "Rubbery" consistency
• 2-5% malignant transformation
• Risk ↑ with time
• Carcinoma ex pleomorphic adenoma
Warthin tumor
(Papillary cystadenoma lymphomatosum)
5-10% of parotid tumors
★ 2nd most common benign
M > F (4:1)
50-70 years
★ Smokers
• Often bilateral (10-15%)
• Cystic with germinal centers
• "Hot" on technetium scan
• Tail of parotid
Virtually never malignant
★ Mucoepidermoid carcinoma 30% of malignant
★ MOST COMMON malignant
Any age
★ Most common in children
• Low/intermediate/high grade
• Mucinous + squamous cells
• t(11;19) translocation
• Painful if high-grade
Malignant by definition
Grade determines prognosis
Adenoid cystic carcinoma 10% of malignant
★ 2nd most common malignant
40-60 years
F = M
• ★ "Swiss cheese" pattern
• ★ Perineural invasion+++
• Slow but relentless growth
• Late distant mets (lung)
Highly malignant
Poor long-term prognosis
Acinic cell carcinoma 5-10% of malignant 40-50 years
F > M
• Bilateral in 3%
• Serous acinar cells
• Usually low-grade
Malignant
Generally good prognosis

 

Note  

⚠️ HIGH-YIELD RULE: Location vs Malignancy Risk

  • Parotid: 20% malignant
  • Submandibular: 40% malignant
  • Sublingual: 80% malignant
  • Minor salivary glands: 80% malignant
  • ★ Remember: "The smaller the gland, the higher the cancer risk"
ملاحظة

 

 

 

سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Clinical features

  • Symptoms
    • Solitary, mobile slow growing painless mass (may be present for many years)
    • Dysphagia and hoarseness
    • Difficult chewing
  • Physical exam
    • Painless, mobile mass found at the angle of the jaw (usually pleomorphic adenoma)
    • Disturbance to facial nerve function (most commonly associated with invasive malignancy)

Version 2

Classic Presentation

**Benign tumor**: Painless, slow-growing, mobile mass present for months to years
**Malignant tumor**: Rapidly growing, fixed mass with pain and facial nerve involvement

Symptoms (in order of frequency)

  1. Palpable mass (>90%)
  2. Pain (suggests malignancy or infection)
  3. Facial nerve palsy 
  4. Dysphagia/hoarseness (deep lobe involvement)
  5. Trismus (advanced disease)

Physical Examination Findings

  • Benign features:
    • Mobile, well-circumscribed
    • Soft to rubbery consistency
    • No facial nerve involvement
    • No skin changes
  • ★ Malignant features (RED FLAGS):
    • Fixed to deep structures
    • Hard consistency
    • Facial nerve palsy (25% of malignant)
    • Skin ulceration
    • Cervical lymphadenopathy
    • Rapid growth (doubling <6 months)
سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Diagnosis

  • Imaging
    • Ultrasound (hypoechoic mass)
    • CT/MRI (necrosis or calcification can be visualized)
  • Serum labs
    • Fine needle aspiration (to assess for malignancy)

 

 

Diagnostic Algorithm

1. **Best initial test**: Ultrasound with FNA 
2. **Most accurate imaging**: MRI with gadolinium 
3. **Gold standard**: Histopathologic examination

Laboratory Studies

  • Fine Needle Aspiration (FNA):
    • Sensitivity: 85-95%
    • Specificity: 95-98%
    • ★ Cannot distinguish follicular lesions
    • Core needle biopsy if FNA non-diagnostic

Imaging Studies

  • Ultrasound:
    • First-line imaging
    • Guides FNA
    • Hypoechoic = suspicious
  • MRI (preferred over CT):
    • Best for deep lobe tumors
    • Perineural spread assessment
    • T1: intermediate signal
    • T2: high signal (most tumors)
  • CT scan:
    • Stone detection (sialolithiasis)
    • Bone involvement
  • ★ Technetium-99m scan:
    • "Hot" = Warthin tumor
    • "Cold" = most others
سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Differential diagnosis

  • Facial nerve schwannoma

 

Version 2

 

Condition Key Distinguishing Feature Test to Differentiate
Lymphoma B symptoms, multiple nodes Flow cytometry
Metastasis Known primary cancer PET-CT
Sialolithiasis Meal-related swelling CT or sialography
Sjögren syndrome Bilateral, dry eyes/mouth Anti-SSA/SSB
HIV parotitis Bilateral, cystic HIV testing
سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Treatment

  • Surgical management
    • Superficial or total parotidectomy (pleomorphic adenoma of the parotid gland)
    • Tumor excision with preservation of nerve (pleomorphic adenoma of the submandibular and minor salivary glands)

 

Version 2

First-Line Treatment

**Benign tumors**: Surgical excision with margins
**Malignant tumors**: Surgery + adjuvant radiation therapy


Surgical Management

  • Parotid tumors:
    • Superficial parotidectomy (lateral to facial nerve)
    • Total parotidectomy (if deep lobe involved)
    • ★ Facial nerve preservation unless invaded
  • Submandibular tumors:
    • Excision of entire gland
    • Level I-II neck dissection if malignant
  • Minor salivary gland tumors:
    • Wide local excision
    • Site-specific approach

 

 

سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Surgical complications

  • Recurrence after resection
  • Malignant transformation

 

Version 2

Most Common Complications

  1. ★ Frey syndrome (gustatory sweating)
    • Incidence: 30-50% post-parotidectomy
    • Aberrant parasympathetic reinnervation
    • Treatment: Botulinum toxin
  2. Facial nerve injury
    • Temporary: 20-30%
    • Permanent: <5% (if nerve preserved)
  3. First bite syndrome
    • Severe pain with first bite
    • Sympathetic denervation

Surgical Complications Timeline

  • Immediate: Hematoma, nerve injury
  • Early: Salivary fistula, infection
  • Late: Frey syndrome, numbness

 

سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

Prognostic Factors

  • Favorable: Small size, low grade, parotid location
  • Poor: High grade, facial nerve involvement, distant mets
سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

HIGH-YIELD FACTS

Must-Know Facts for Exams:

1. Most common benign: Pleomorphic adenoma
2. Most common malignant: Mucoepidermoid carcinoma
3. Bilateral tumors: Think Warthin (smokers) or lymphoma

سجل دخولك لإضافة ملاحظات خاصة لكل قسم  · اشترك الآن

احصل على التجربة الكاملة

اشترك للوصول لفيديوهات الشرح التفصيلي والبطاقات التعليمية التفاعلية وأسئلة الممارسة مع تتبع التقدم.

فيديوهات الشرح بطاقات تفاعلية أسئلة ممارسة
اشترك الآن

المساعد الطبي الذكي

اسأل أسئلة حول المحتوى الطبي واحصل على إجابات فورية مدعومة بالذكاء الاصطناعي

اشترك الآن

سجل دخولك لاستخدام أدوات الدراسة

اشترك الآن